SCHEMBL4777512

SCHEMBL4777512

O=C(O)N1CCC(CSc2ccc(F)cc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
PKM P14618 3/20 0.44
GAA P10253 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CRBN Q96SW2 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 1/20 0.41
CTSK P43235 1/20 0.40
CACNA1B Q00975 1/20 0.39
HSD11B1 P28845 2/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
DRD2 P14416 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HTR2B P41595 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4771613 0.99 ALDH1A1 (0.43) ALDH1A1PKMGAAL3MBTL1CRBN
SCHEMBL15477388 0.86 SMN1; SMN2 (0.48) ALDH1A1PKMSMN1; SMN2NPC1RAB9A
SCHEMBL17942512 0.83 CTSK (0.44) ALDH1A1SMN1; SMN2NPC1RAB9ACTSK
SCHEMBL17942449 0.78 KDM6B (0.33) ALDH1A1SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL4097076 0.77 CCR5 (0.42) ALDH1A1L3MBTL1CRBNNPC1RAB9A
SCHEMBL2925616 0.77 MEN1 (0.60) ALDH1A1MEN1POLBKMT2AKDM4E
SCHEMBL7363385 0.76 DRD2 (0.54) CRBNDRD2HTR2AHTR2CHTR2B
SCHEMBL21820657 0.76 CRBN (0.49) ALDH1A1L3MBTL1CRBNSMN1; SMN2NPC1
SCHEMBL22585179 0.75 HDAC3 (0.44) ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL19994566 0.75 MAOB (0.56) MEN1POLBKMT2AHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7348324-B2 Cyclic amine compounds as CCR5 antagonists TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-03-25 US disclosed
EP-1886994-A1 Cyclic amine compounds as CCR5 antagonists Takeda Pharmaceutical Company Limited (JP) 2008-02-13 EP disclosed
US-20030114443-A1 Cyclic amine compounds as CCR5 antagonists TOBIRA THERAPEUTICS, INC. 2003-06-19 US disclosed
US-6562978-B1 N-(3-(4-(4-(Aminocarbonyl)benzyl)-1-piperidinyl)propyl)-N-(3, 4-dichlorophenyl)-1-(methylsulfonyl)-4-piperidinecarboxamide or a salt thereof for treatment of AIDS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-05-13 US disclosed
CN-1390201-A cyclic amine compounds as CCR5 antagonists TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-01-08 CN disclosed
EP-1220842-A1 CYCLIC AMINE COMPOUNDS AS CCR5 ANTAGONISTS Takeda Chemical Industries, Ltd. (JP) 2002-07-10 EP disclosed
WO-2001025200-A1 CYCLIC AMINE COMPOUNDS AS CCR5 ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030114443-A1 Cyclic amine compounds as CCR5 antagonists CCR5, CCR1, CCR3 ALDH1A1 3228/4885PKM 4190/4885GAA 4215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.